Shariatga muvofiqlik sharhi
HalolLigand Pharmaceuticals Incorporated (LGND) hozirda Akinda shariat skriningi (AAOIFI) bo'yicha Halol deb tasniflanadi.
Ligand Pharmaceuticals Incorporated haqida
Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions.
Ligand Pharmaceuticals Incorporated (LGND) Healthcare sektorida, Biotechnology sohasida faoliyat yuritadi.
Nega halol: aksiya AAOIFI ning uchala tekshiruvidan o'tadi. Nomuvofiq daromad — 4.85% (chegara 5%), foizli qarz — 14.92% (chegara 30%), foizli qimmatli qog'ozlar va aktivlar — 24.53% (chegara 30%).
Agar sizda LGND aksiyasi bo'lsa, daromadning nomuvofiq qismini poklash uchun olgan dividendlaringizning 4.85% qismini xayriyaga bering.
- Kompaniya faoliyati
- 4.85%Chegara 5%Muvaffaq
- Foizli qarz
- 14.92%Chegara 30%Muvaffaq
- Foizli qimmatli qog‘ozlar va aktivlar
- 24.53%Chegara 30%Muvaffaq
- Dividendlarni poklash
- 4.85%Xayriyaga beriladigan dividend ulushiPoklash kalkulyatori
Oxirgi yangilanish: 3-noy, 2026 · Skrining ma'lumot uchun; bu fatvo emas. Shaxsiy maslahat uchun malakali olim bilan maslahatlashing.
Kontentni ko'rish uchun tizimga kiring
Kontentni ko'rish uchun tizimga kiring
Kontentni ko'rish uchun tizimga kiring
Kompaniya profili
Kontentni ko'rish uchun tizimga kiring
Tez-tez beriladigan savollar
Ligand Pharmaceuticals Incorporated (LGND) bo‘yicha qisqa javoblar. Akinda skrining yorlig‘i: Halol.
